蓝帆医疗：控股子公司产品拟中选冠脉药涂球囊集采

Core Viewpoint - The announcement indicates that the company’s subsidiary, Shandong Jiwei Medical Products Co., Ltd., is participating in a national centralized procurement for coronary drug-coated balloons, with a proposed winning price of 2,524 yuan [1] Group 1: Product and Procurement Details - The product involved in the procurement is a coronary drug-coated balloon, categorized under bidding unit A [1] - The procurement cycle is set to last until December 31, 2028, which could enhance the market influence of the company's drug-coated balloon products if a procurement agreement is signed and executed [1] Group 2: Uncertainty and Impact - The final selection results have not been announced, and the procurement agreement has not been signed, leading to uncertainty regarding the impact on the company's performance [1]